VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,927 | -35.3% | 3,941 | +69.3% | 0.00% | – |
| Q2 2023 | $57,106 | +13.1% | 2,328 | +7.3% | 0.00% | – |
| Q1 2023 | $50,473 | +81.5% | 2,169 | +97.4% | 0.00% | – |
| Q4 2022 | $27,816 | +26.4% | 1,099 | -1.6% | 0.00% | – |
| Q3 2022 | $22,000 | -21.4% | 1,117 | +0.8% | 0.00% | – |
| Q2 2022 | $28,000 | +7.7% | 1,108 | +10.8% | 0.00% | – |
| Q1 2022 | $26,000 | 0.0% | 1,000 | +60.0% | 0.00% | – |
| Q4 2021 | $26,000 | -3.7% | 625 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -10.0% | 625 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | -6.2% | 625 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | -3.0% | 625 | -50.0% | 0.00% | – |
| Q4 2020 | $33,000 | -23.3% | 1,250 | 0.0% | 0.00% | – |
| Q3 2020 | $43,000 | +38.7% | 1,250 | +66.7% | 0.00% | – |
| Q2 2020 | $31,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |